Labetalol |
Normodyne; Trandate |
Labetalol Systematic (IUPAC) name 2-hydroxy-5-[1-hydroxy-2- (4-phenylbutan-2-ylamino)-ethyl]-benzamide Identifiers CAS number 36894-69-6 ATC code C07AG01 PubChem 3869 DrugBank APRD01062 Chemical data Formula C19H24N2O3 Mol. weight 328.406 g/mol Pharmacokinetic data Bioavailability 100% Protein binding 50% Metabolism hepatic pass metabolism, Half life Tablet: 6-8 hours; IV: 5.5 hours Excretion Excreted in urine, not removed by hemodialysis Therap ...
Wikipedia - [full article]
Labetalol Clinical Trials
- Effects of Labetalol on Nicotine Administration in Humans - 14
ClinicalTrials.gov Identifier: NCT00000297 - Completed
Tobacco Use Disorder
- Effects of Labetalol on Human Cocaine Use - 8
ClinicalTrials.gov Identifier: NCT00000291 - Completed
Cocaine-Related Disorders
- Labetalol Versus MgSO4 for the Prevention of Eclampsia Trial
ClinicalTrials.gov Identifier: NCT00293735 - Recruiting
Preeclampsia; Pregnancy Induced Hypertension; Gestational Hypertension; Chronic Hypertension; Superimposed Preeclampsia
- Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage
ClinicalTrials.gov Identifier: NCT00226096 - Active, not recruiting
CVA (Cerebrovascular Accident); Cerebral Hemorrhage; Intracranial Hemorrhages
- Labetalol to Prevent Hypertension and Tachycardia During Fiberoptic Bronchoscopy
ClinicalTrials.gov Identifier: NCT00394537 - Completed
Bronchoscopy

Not Signed In -

